Your browser doesn't support javascript.
loading
Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.
Taromi, Sanaz; Lewens, Florentine; Arsenic, Ruza; Sedding, Dagmar; Sänger, Jörg; Kunze, Almut; Möbs, Markus; Benecke, Joana; Freitag, Helma; Christen, Friederike; Kaemmerer, Daniel; Lupp, Amelie; Heilmann, Mareike; Lammert, Hedwig; Schneider, Claus-Peter; Richter, Karen; Hummel, Michael; Siegmund, Britta; Burger, Meike; Briest, Franziska; Grabowski, Patricia.
Afiliação
  • Taromi S; Department of Medicine, Division of Hematology and Oncology, University Medical Center, Freiburg, Germany.
  • Lewens F; Department of Gastroenterology, Infectious Diseases, Rheumatology CC13, Charité-Universitätsmedizin, Berlin, Germany.
  • Arsenic R; Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany.
  • Sedding D; Department of Gastroenterology, Infectious Diseases, Rheumatology CC13, Charité-Universitätsmedizin, Berlin, Germany.
  • Sänger J; Institute of Pathology, Bad Berka, Germany.
  • Kunze A; Institute of Pathology, Bad Berka, Germany.
  • Möbs M; Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany.
  • Benecke J; Department of Gastroenterology, Infectious Diseases, Rheumatology CC13, Charité-Universitätsmedizin, Berlin, Germany.
  • Freitag H; Department of Gastroenterology, Infectious Diseases, Rheumatology CC13, Charité-Universitätsmedizin, Berlin, Germany.
  • Christen F; Department of Medical Immunology, Charité Universitätsmedizin, Berlin, Germany.
  • Kaemmerer D; Department of Gastroenterology, Infectious Diseases, Rheumatology CC13, Charité-Universitätsmedizin, Berlin, Germany.
  • Lupp A; Institute of Biology, Humboldt-Universität, Berlin, Germany.
  • Heilmann M; Department of General and Visceral Surgery, Zentralklinik Bad Berka GmbH, Bad Berka, Germany.
  • Lammert H; Institute of Pharmacology and Toxicology, Jena University Hospital, Jena, Germany.
  • Schneider CP; Department for Oncology, Zentralklinik Bad Berka GmbH, Bad Berka, Germany.
  • Richter K; Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany.
  • Hummel M; Department for Oncology, Zentralklinik Bad Berka GmbH, Bad Berka, Germany.
  • Siegmund B; Department for Oncology, Zentralklinik Bad Berka GmbH, Bad Berka, Germany.
  • Burger M; Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany.
  • Briest F; Department of Gastroenterology, Infectious Diseases, Rheumatology CC13, Charité-Universitätsmedizin, Berlin, Germany.
  • Grabowski P; Department of Medicine, Division of Hematology and Oncology, University Medical Center, Freiburg, Germany.
Oncotarget ; 8(57): 97061-97078, 2017 Nov 14.
Article em En | MEDLINE | ID: mdl-29228593
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha